HR+ BREAST CANCER

Clinical trials for HR+ BREAST CANCER explained in plain language.

Never miss a new study

Get alerted when new HR+ BREAST CANCER trials appear

Sign up with your email to follow new studies for HR+ BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 3 Terminated 1

First human trial begins for new cancer pill targeting advanced tumors

Disease control Recruiting now

This is the first study in people to test a new oral pill called NKT5097 for adults with advanced or metastatic solid tumors, with a focus on certain breast, ovarian, and uterine cancers. The main goals are to find a safe dose and understand the side effects. Researchers will als…

Matched conditions: HR+ BREAST CANCER

Phase: PHASE1 • Sponsor: NiKang Therapeutics, Inc. • Aim: Disease control

Last updated Mar 27, 2026 12:38 UTC

HR+ BREAST CANCER

Get alerted when new HR+ BREAST CANCER trials appear

First human trial begins for new cancer pill targeting advanced tumors